Capula Management »

Ligand Pharmaceuticals In shares owned by Capula Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Capula Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $893k 15k 59.92
2023-06-30 $564k 7.8k 72.10
2022-12-31 $778k 12k 66.80

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Strategy Cl A New Put Option (MSTR)
UnitedHealth Put Option (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Coinbase Global Com Cl A Call Option (COIN)
Apple (AAPL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Nike CL B (NKE)
Dell Technologies CL C (DELL)

View all positions for Capula Management

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Congress Asset Management
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In